.png)
.png)
Professor
University of Washington
Disclosure(s): Aicuris: Advisor/Consultant; Auritec: Advisor/Consultant; Crozet: Advisor/Consultant; DXNow: Advisor/Consultant; GSK: Grant/Research Support; Merck: Advisor/Consultant; sanofi: Grant/Research Support; VIR: Advisor/Consultant; X-Vax: Advisor/Consultant
Anna Wald, MD, MPH, FIDSA, is the Head of Allergy and Infectious Diseases Division, Professor of Medicine, Epidemiology, and Laboratory Medicine & Pathology at the University of Washington and at the Vaccine and Infectious Division, Fred Hutchinson Cancer Research Center. Dr. Wald directs the University of Washington Virology Research Clinic, a clinic dedicated to the study of epidemiology, natural history, and therapeutics for viral infections. Her research has focused on genital herpes infections, including infections in pregnant women and immunocompromised hosts. She has been an investigator in many clinical trials for novel antiviral agents, and prophylactic and therapeutic vaccines for HSV infection, as well as vaccines for HPV, CMV and other viral pathogens. In the last few years, she has participated in multiple trials of therapeutic agents and investigational vaccines for SARS-CoV-2.
Dr. Wald has been supported by NIH throughout her career. In addition to grants for scientific investigations, she has received a K24 Mentor Award from NIAID which supported the mentoring of the next generation of physician scientists.